2025.12.09 ALBERT BOURLA--CME STEM Leadership Awards NY, Honoree for Lifetime Achievement

📅 Dec 14, 2025 CME-STEM 8 MIN 121 VIEWS 11 SEGMENTS · 2 SPEAKERS

What an extraordinary celebration of the 13th Annual Edition of the CME STEM Leadership Awards and CME's 71 years of STEM-driven innovation and progress. A day of inspiration, connection, and forward-thinking vision—truly unforgettable! We honored trailblazing leaders: ✨ Albert Bourla, PhD, DVM, CEO of Pfizer – Recipient of the Lifetime Achievement Award for his transformative impact on global health. ✨ David Spergel, PhD, President of the Simons Foundation – Honored with the Advancing Fundamental Research Award for pushing the boundaries of scientific discovery. ✨ Anthony O’Donovan, PhD, CEO...

Narrator 0:05 ↗

Ladies and gentlemen, it is my privilege to present the 2025 CME STEM Leadership Award for Lifetime Achievement to a fearless leader, a brilliant scientist, and a steadfast champion of innovation and STEM talent, Dr. Albert Bourla.

1 more exchange in this transcript

Cite this transcript

APA, MLA, BibTeX

APA

Bourla, A. (2025, December 14). 2025.12.09 ALBERT BOURLA--CME STEM Leadership Awards NY, Honoree for Lifetime Achievement [Interview transcript]. CME-STEM. CEOInterviews.AI. https://ceointerviews.ai/interview/774983/

MLA

Albert Bourla. "2025.12.09 ALBERT BOURLA--CME STEM Leadership Awards NY, Honoree for Lifetime Achievement." CME-STEM, 14 Dec. 2025. Transcript, CEOInterviews.AI, https://ceointerviews.ai/interview/774983/.

BibTeX

@misc{bourla2025_774983,
  author       = {Albert Bourla},
  title        = {2025.12.09 ALBERT BOURLA--CME STEM Leadership Awards NY, Honoree for Lifetime Achievement},
  howpublished = {Interview transcript, CME-STEM. CEOInterviews.AI},
  year         = {2025},
  month        = {dec},
  url          = {https://ceointerviews.ai/interview/774983/},
  note         = {Speaker-attributed transcript with timestamps}
}

▶

Key Quotes (2)

“I believe and I truly believe that it is within our reach to make traditional chemotherapy obsolete within a decade.”

CONTROVERSIAL

“At Pfizer, we were able to prove that during the pandemic — probably the most profound demonstration of teamwork where thousands of people among our company worked to make sure that the world would have a solution that saved lives, the coherence of society and the economy.”

POLICY

Newsletters that week

Does mRNA technology-based COVID vaccine (Pfizer & Moderna) already contain DNA? Plasmids? Kevin McKernan? Is the finding by Aldén et al. thAlexander News Network (ANN): Trump's War 2.0 for America · Alexander News Network (ANN): Trump's War 2.0 for America · Dec 20, 2025
FDA Won’t ‘Rubber-Stamp’ Pfizer mRNA Flu Vaccine Without Better Safety DataThe Defender · The Defender · Dec 16, 2025
FDA Won’t ‘Rubber-Stamp’ Pfizer mRNA Flu Vaccine Without Better Safety Data/ The DefenderMeryl’s CHAOS letter (Critical Health Analysis and OpinionS) · Meryl’s CHAOS letter (Critical Health Analysis and OpinionS) · Dec 15, 2025
PFIZER EMPLOYEES HAVE TO BE FORCED INTO ACCOUNTABILITY!Alicia’s Newsletter · Alicia’s Newsletter · Dec 14, 2025
“THE PFIZER PAPERS: The Hidden War on Humanity” Exposes the Greatest Medical Betrayal of Our TimeTuzara Post Newsletter · Joe Tuzara, M.D. @TuzaraPost · Dec 11, 2025

More interviews with Albert Bourla

Pfizer CEO Albert Bourla on AI and the future of medicineSep 30, 2026 · AtlanticCouncil · 27 min
Pfizer’s Albert Bourla on AI, health, and innovation in a changing worldSep 22, 2026 · AtlanticCouncil · 64 min
Pfizer CEO Albert Bourla on the Future of PharmaAug 18, 2026 · TIME · 36 min
#249 – Albert Bourla: Pfizer CEOAug 05, 2026 · Family Cartoon · 74 min
'CROWN JEWEL': Pfizer CEO touts 'TREMENDOUS SUCCESSES' in oncology R&DJul 04, 2026 · Fox Business · 8 min
Albert Bourla on the State of PharmaMay 20, 2026 · WSJ Events · 28 min

All Albert Bourla transcripts →

Also at Pfizer Inc

Sally SusmanFormer Executive VP & Chief Corporate Affairs Officer

All Pfizer executives →

About Albert Bourla

Albert Bourla, chairman and CEO of Pfizer, discussed the role of artificial intelligence in healthcare during appearances in September 2026 at Atlantic Council events held on the sidelines of the United Nations General Assembly. He described AI as a transformative force in drug discovery, development, manufacturing, and marketing, while also acknowledging risks, including the potential for AI tools to be used to engineer biological threats. Bourla said the COVID-19 pandemic represented an existential threat with no upside, whereas AI presents both threats and opportunities, and he expressed a belief that humanity generally progresses toward improvement over time. He also commented on US-China relations in biotech, stating that the two countries should both cooperate and compete, and praised China's scientific capabilities. In an August 2026 interview with TIME, Bourla reflected on Pfizer's post-pandemic challenges, including a decline in stock price, and described his focus on finding a new path and rallying the organization. He discussed Pfizer's entry into the obesity treatment market, citing the high need and the company's capabilities in primary care. During Pfizer's Q2 2026 earnings call, Bourla stated that the company views AI as a structural transformation opportunity to accelerate its R&D pipeline and improve productivity. He also said Pfizer was confident it could maintain its dividend even in stretched scenarios, with plans to resume growth after the loss of exclusivity period. Bourla has previously stated that the pharmaceutical industry's reputation suffered in the last decade and that behavior within the industry needed to change.

All Albert Bourla appearances → CME-STEM on YouTube →